airway solutions
Evidence
Ventubation™ Systems is committed to providing clinical evidence to support use of this revolutionary system. The Ventubation System is supported by preclinical testing with early cadaver and manikin studies.
Whitepapers
The Ventubation System for Continuous Airway Control: Results of A Pilot Usability Study
Emergency airway management carries a high risk of peri-intubation major adverse events, including hypoxemia, hemodynamic instability, and cardiac arrest. Apnea duration and first-attempt success are two of the most important modifiable factors influencing these outcomes. This white paper presents pilot usability data for a novel airway management system designed to reduce apnea time and improve first-pass success. In a manikin evaluation, the system reduced mean apnea time by 67% and time to cuff inflation by 27% compared with standard direct laryngoscopy, supporting further evaluation in prehospital airway management.
Proof-of-Concept Leak Pressure Validation of the SupraVent Dual-Lumen Supraglottic Intubating and Ventilating Device
The Ventubation System™ combines the SupraVent™ supraglottic ventilating and intubating device with the IntroGard™ endotracheal tube introducer. To evaluate whether the SupraVent’s one-way valve and longitudinal split compromise the laryngeal seal, we compared it with two commercially available supraglottic airway devices in three non-embalmed human cadavers. The SupraVent achieved leak pressures of 20–26 cmH₂O, matching the cuffed LMA within 1–3 cmH₂O in every specimen. These findings demonstrate that its valve-and-slit architecture maintains a laryngeal seal comparable to existing cuffed and non-inflatable cuff SGAs